Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NEFAZODONE vs NEMOLIZUMAB-ILTO: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NEFAZODONE vs NEMOLIZUMAB-ILTO: Safety Overview

Metric NEFAZODONE NEMOLIZUMAB-ILTO
Total FAERS Reports 284 4,183
Deaths Reported 11 32
Death Rate 3.9% 0.8%
Hospitalizations 37 115
Average Patient Age 56.4 yrs 53.4 yrs
% Female Patients 66.6% 73.1%
FDA Approval Date Dec 22, 1994 N/A
Manufacturer Teva Pharmaceuticals USA, Inc. N/A
Route ORAL N/A
Marketing Status Discontinued Prescription